Remove spotlight spotlight-future-generics
article thumbnail

ACI’s 16th Annual Paragraph IV Disputes Conference (and It’s In-Person!)

FDA Law Blog

A “Who’s Who of the Food Law Bar” will give you critical insights in sessions like: “Forecasting the Future of Pharmaceutical Patent Litigation: Trends, Legal Analyses and Business Prognoses Post-Covid”. Spotlight on Delaware: District Court Judges Address Brand and Generic Concerns”. The PTAB Live!

article thumbnail

Deep Dive: Communications and Commercialisation

pharmaphorum

This issue assesses European pharma’s approach to strategic communications, the future of pharma commercialisation, communications gaps with patients and, with the pandemic continuing to cast a long shadow over healthcare, how to maximise the effectiveness of HCP engagement. Company Spotlight: The Method.

Doctors 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Statins PROS and CONS [TOP LIST]

Druggist

In 2019, the availability of high dose statins came into a spotlight again, after the announcement by NHS that statins may be available from pharmacie s without a prescription (NHS, 2019). The above statins may come in generic form or as branded medicines. Availability of high dose statins over the counter. simvastatin. pravastatin.

Drugs 52
article thumbnail

American Conference Institute’s Premiere Conference on Life Sciences Antitrust

pharmaphorum

As we proceed through 2021, the spotlight on antitrust activity in the life sciences industry shines brighter than ever. Recent Criminal Generic Price Fixing Cases and How They May Change the Outlook for Competition in the Industry. For several years, state and federal antitrust enforcers in the U.S.

article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

In this in-depth article, we embark on a captivating journey to uncover the top 30 pharma and biotech companies that have been instrumental in shaping the future of medicine. These collaborations will allow Moderna to expedite the production of its foremost mRNA products and equip itself for future pandemics.

Sales 98